Cell Biology Co-Op

Company Summary:

FL87, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.

FL87 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ:MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.

Position Summary:

We are seeking a motivated Co-op to support efforts characterizing nucleic acid expression and function using in vitrocell-based assays. This individual will be focused on hands-on laboratory benchwork, will bring thoroughness and attention to detail, and will be scientifically curious. The candidate will have the opportunity to work alongside a highly collaborative team in a fast-paced environment.

Key Responsibilities:

• Culture and maintenance of cell lines and primary cells
• Execute, troubleshoot and analyze data from cell-based assays evaluating nucleic acid function
• Contribute to assay development efforts in a data-informed manner as required
• Maintain up-to-date, excellent record keeping and share experimental methods and data effectively in both oral and written formats
• Multitask between projects and pivot on experimental priorities as needed in alignment with company goals
• Comfortable working independently and as part of a collaborative, multidisciplinary team

Qualifications:

• Current enrollment in a BS or MS program in Biology, Immunology, Virology, or related field
• Laboratory skills relevant to a biosafety level 2 environment and cell culture work are required
• Experience with experimental design and hands-on execution of in vitro cell-based assays (e.g. flow cytometry, Incucyte-based and/or confocal imaging, luminescence-based assays) is preferred
• Experience with nucleic acid delivery methods (transfection, nucleofection, LNP) is preferred
• Highly motivated to execute at the bench and bring strong organizational and problem-solving skills
• Strong interpersonal and communication skills 
• Rigorous attention to detail and enthusiasm towards developing new skills
• Ability to adapt, execute, absorb and implement learnings, and thrive in a fast-paced, multidisciplinary and rapidly growing biotech environment 

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunitiesacross Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are

The pay range for this role is $25 - $35 per hour. This role is a short-term engagement that is not eligible for health and welfare benefits. Retirement benefits may be available after completing a set number of hours. Compensation and benefits information is based on FL87's good faith estimate as of the date of publication and may be modified in the future.